PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1086324
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1086324
Viral vectors aids in transferring genetic material into target cells and therefore, used in various therapeutic areas. Viral vectors can be significantly used in vaccines development against pathogens such as Mycobacterium tuberculosis, Plasmodium falciparum, HIV, and various bio-threat targets such as filoviruses. Plasmid DNA (pDNA) is gaining traction for clinical research applications in genetic vaccination and gene therapy. It is becoming increasingly useful as novel biotechnology product for DNA vaccines and gene medicines. It can be directly used as a therapeutic agent and indirectly used for various applications such as a starting material for transient transfection to produce transient proteins and viral vector constructs. Furthermore, pDNA is used as a master-template product to support production of new and developing biopharmaceutical products and processes such as cell therapies.
Increasing approvals by regulatory authorities for novel gene therapies is expected to drive growth of the gene therapy segment. For instance, in September 2017, GeneOne Life Science, Inc., received approval from the South Korean Ministry of Food and Drug Safety (KMFDS) for an Investigational New Drug application for a Phase I/IIa study of its investigational vaccine, GLS-5300, against the Middle East Respiratory Syndrome coronavirus (MERSCoV). Moreover, in May 2019, AveXis Inc. received the U.S. Food and Drug Administration approval for its Zolgensma (onasemnogene abeparvovec-xioi), an adeno-associated virus vector-based gene therapy for the treatment of pinal muscular atrophy (SMA) in children less than two years old.
? Retroviral Vectors
? Adenoviral Vectors
? Lentiviral Vectors
? Adeno-associated Viral Vectors
? Others
? By Product Type:
? Viral Vector
? Retroviral Vectors
? Adenoviral Vectors
? Lentiviral Vectors
? Adeno-associated Viral Vectors
? Others
? Plasma DNA
? Non-viral DNA Vectors
? By Therapeutic Application:
? Cancer
? Inherited Disorders
? Infectious Diseases
? Others
? By End Product:
? DNA Vaccines
? Gene Therapy
? Immunotherapy
? Others
? By Country:
? U.S.
? Canada
? By Product Type:
? Viral Vector
? Retroviral Vectors
? Adenoviral Vectors
? Lentiviral Vectors
? Adeno-associated Viral Vectors
? Others
? Plasma DNA
? Non-viral DNA Vectors
? By Therapeutic Application:
? Cancer
? Inherited Disorders
? Infectious Diseases
? Others
? By End Product:
? DNA Vaccines
? Gene Therapy
? Immunotherapy
? Others
? By Country:
? Brazil
? Mexico
? Argentina
? Rest of Latin America
? By Product Type:
? Viral Vector
? Retroviral Vectors
? Adenoviral Vectors
? Lentiviral Vectors
? Adeno-associated Viral Vectors
? Others
? Plasma DNA
? Non-viral DNA Vectors
? By Therapeutic Application:
? Cancer
? Inherited Disorders
? Infectious Diseases
? Others
? By End Product:
? DNA Vaccines
? Gene Therapy
? Immunotherapy
? Others
? By Country:
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
? By Product Type:
? Connected
? Regular Viral Vector
? Retroviral Vectors
? Adenoviral Vectors
? Lentiviral Vectors
? Adeno-associated Viral Vectors
? Others
? Plasma DNA
? Non-viral DNA Vectors
? By Therapeutic Application:
? Cancer
? Inherited Disorders
? Infectious Diseases
? Others
? By End Product:
? DNA Vaccines
? Gene Therapy
? Immunotherapy
? Others
? By Country:
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of Asia Pacific
? By Product Type:
? Viral Vector
? Retroviral Vectors
? Adenoviral Vectors
? Lentiviral Vectors
? Adeno-associated Viral Vectors
? Others
? Plasma DNA
? Non-viral DNA Vectors
? By Therapeutic Application:
? Cancer
? Inherited Disorders
? Infectious Diseases
? Others
? By End Product:
? DNA Vaccines
? Gene Therapy
? Immunotherapy
? Others
? By Country:
? GCC
? Israel
? Rest of Middle East
? By Product Type:
? Viral Vector
? Retroviral Vectors
? Adenoviral Vectors
? Lentiviral Vectors
? Adeno-associated Viral Vectors
? Others
? Plasma DNA
? Non-viral DNA Vectors
? By Therapeutic Application:
? Cancer
? Inherited Disorders
? Infectious Diseases
? Others
? By End Product:
? DNA Vaccines
? Gene Therapy
? Immunotherapy
? Others
? By Country/Region:
? South Africa
? Central Africa
? North Africa
? Company Overview
? Material Portfolio
? Financial Performance
? Key Highlights
? Market Strategies
"*" marked represents similar segmentation in other categories in the respective section.